
Akeso Inc Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Akeso Inc
Access all reports
Akeso Inc is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of innovative therapies. The company focuses on oncology, immunology, and other therapeutic areas, utilizing its proprietary research platforms to develop monoclonal antibody drugs. The company is headquartered in Zhongshan, China, and its shares are listed on the SEHK.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
9926
Country
🇭🇰 Hong Kong